A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
|Videos|August 25, 2020
Addressing health care disparities: A simple way to better serve your patients
Vanessa L. Rogers, MD, shares her expert insight into ways practitioners can address health care disparities in their area and provide patients with better care.
Advertisement
"Disparities you find depending on which zip code you live in are dramatic," says Dr. Rogers.
Watch the full,
Advertisement
Related to this article
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Earlier menopause associated with less favorable functional, structural neurological outcomes
2
FDA holding public meeting on testosterone use in menopausal women
3
Off-label testosterone dosing, access, and lab monitoring in the US
4
Pellet therapy and practical advice for hesitant prescribers
5